Categories: News

Coloplast A/S – Q1 2023/24 Earnings Release – Invitation for conference call on 9 February 2024 at 11.00am CET

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

Friday, 9 February 2024 at 11.00 – 12.00 CET
In connection with the publication of Coloplast’s interim financial results for Q1 2023/24, to be released same day around 07.30 am CET, Coloplast will host a conference call to present the financial results and answer questions from investors and financial analysts. A presentation will be available on Coloplast’s website approximately 1 hour before the conference call.
The webcast of the conference call will be available during and after the event.

Coloplast will be represented by:
Kristian Villumsen – President & CEO
Anders Lonning-Skovgaard  Executive Vice President, CFO
Aleksandra Dimovska – Senior Director, Investor Relations
Kristine Husted Munk – Senior Manager, Investor Relations

Webcast
For participants who do not wish to actively participate in the Q&A session, please access the conference call as a webcast via the link below:
Access the webcast here


Dial-in details
To actively participate in the Q&A session, please sign up ahead of the conference call on the link below to receive an email with dial-in details.
Register for the conference call here

 

For more information, please contact:

Aleksandra Dimovska – Senior Director, Investor Relations
Tel.: +45 4911 1800 / direct: +45 4911 2458. E-mail: dkadim@coloplast.com

Kristine Husted Munk – Senior Manager, Investor Relations
Tel.: +45 4911 1800 / direct: +45 4911 3266. E-mail: dkkhu@coloplast.com

Hannah K. Larsen – Coordinator & PA, Investor Relations
Tel.: +45 4911 1800 / direct: +45 4911 3616. E-mail: dkhakl@coloplast.com

 

Coloplast will be available on individual phone lines after the conference call for further questions.

Attachment

Staff

Recent Posts

INDY 500 Stars Join Forces with ZERO Prostate Cancer to Put Veterans’ Health in the Spotlight at Memorial Day Weekend Races

INDIANAPOLIS, May 23, 2025 /PRNewswire/ -- This Memorial Day Weekend, the spotlight won't only be on…

15 hours ago

Caris Life Sciences Files Registration Statement for Proposed Initial Public Offering

IRVING, Texas, May 23, 2025 /PRNewswire/ -- Caris Life Sciences® ("Caris"), a leading, patient-centric, next-generation AI…

15 hours ago

Movano Health Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Report on Form 10-Q

PLEASANTON, Calif., May 23, 2025 /PRNewswire/ -- Movano Health (Nasdaq: MOVE)(the "Company") announced today that…

15 hours ago

Yardi Expert David Bellew elected to Argentum Board of Directors

Senior director of Senior Living Suite joins board of national senior living industry association SANTA…

15 hours ago

Evidently Hires Andrés Krogh-Walker as Head of Marketing

The clinical data intelligence platform continues executive team expansion following $15 million funding round PALO…

21 hours ago

Quantum Sensors Market to Hit USD 839 Million by 2031 | Key Growth in Defense, Healthcare & IT – Valuates Reports

BANGALORE, India, May 23, 2025 /PRNewswire/ -- Quantum Sensors Market is Segmented by Type (Atomic…

21 hours ago